A biologic is a material that energetically alters its surrounding atmosphere and effects a change during a biological process. Spine biologics are used through spine fusion surgical treatment for the treatment of spinal defect includes wound, degenerative disc illness, tumors, and spinal cord injuries and wounds by stimulating bone growth formation through inflammatory repair stage, stage and remodeling stage. Thus, flow in the quantity of spinal fusion surgeries has fueled the acceptance of biologics.
The spinal devices and biologics market is expected to be around USD 19700.40 million by 2028, at a CAGR of 17.00% during the forecast period 2023 to 2028.
Technical expansion in spine surgery equipment, and increasing aging and obese population plus rising range of spine deformities, and surging demand for minimally persistent spine surgery process are the most factors that are expected to fuel the growth of the spinal devices and biologics industry. However, the severe product approval process, ambiguity in compensation, and soaring cost of cure procedures are varied factors expected to create a challenge for growth of this market. Moreover, shortage of adequate patient awareness concerning novel developed treatment technologies and methods and soaring pricing pressure on industry players are other factors obstructing the expansion.
Market Insights
The global Spinal Devices and Biologics market is segregated on the basis of Application as Hospitals, Ambulatory Surgical Centers, Clinics, and Other. Based on Type the global Spinal Devices and Biologics market is segmented in Spinal Fusion & Fixation, Motion Preservation, Non-Fusion Technologies, Fracture Treatment, and Other.
The global Spinal Devices and Biologics market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Spinal Devices and Biologics market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Rivalry
Nuvasive, Orthofix International, Exactech, Wright Medical Group, Johnson & Johnson, Zimmer Biomet, Globus Medical, K2M, Medtronic, Alphatec Holdings, and others are among the major players in the global Spinal Devices and Biologics market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The Spinal Devices and Biologics Market has been segmented as below:
Spinal Devices and Biologics Market, By Application
Spinal Devices and Biologics Market, By Type
Spinal Devices and Biologics Market, By Region
Spinal Devices and Biologics Market, By Company
The report covers:
Report Scope:
The global Spinal Devices and Biologics market report scope includes detailed study covering underlying factors influencing the industry trends.
The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies.
The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Spinal Devices and Biologics market share. Major industry players with significant revenue share include Nuvasive, Orthofix International, Exactech, Wright Medical Group, Johnson & Johnson, Zimmer Biomet, Globus Medical, K2M, Medtronic, Alphatec Holdings, and others.
Reasons to Buy this Report:
Customization
Customized report as per the requirement can be offered with appropriate recommendations
Below are our new reports:
Surgical Site Infection Control Market
Tinnitus Management Devices Market
Oncology Devices Market
Breast Lesion Guidance Systems Market
1. Introduction
1.1 Key Insights
1.2 Report Overview
1.3 Markets Covered
1.4 Stakeholders
2. Research Methodology
2.1 Research Scope
2.2 Market Research Process
2.3 Research Data Analysis
2.4.1 Secondary Research
2.4.2 Primary Research
2.4.3 Models for Estimation
2.5 Market Size Estimation
2.5.1 Bottom-Up Approach – Segmental Market Analysis
2.5.2 Top-Down Approach – Parent Market Analysis
3. Executive Summary
4. Market Overview
4.1 Introduction
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Challenges
4.2 Porter’s Five Force Analysis
5. Spinal Devices and Biologics Market, By Application
5.1 Introduction
5.2 Hospitals
5.2.1 Market Overview
5.2.2 Market Size and Forecast
5.3 Ambulatory Surgical Centers
5.3.1 Market Overview
5.3.2 Market Size and Forecast
5.4 Clinics
5.4.1 Market Overview
5.4.2 Market Size and Forecast
5.5 Other
5.5.1 Market Overview
5.5.2 Market Size and Forecast
6. Spinal Devices and Biologics Market, By Type
6.1 Introduction
6.2 Spinal Fusion & Fixation
6.2.1 Market Overview
6.2.2 Market Size and Forecast
6.3 Motion Preservation
6.3.1 Market Overview
6.3.2 Market Size and Forecast
6.4 Non-Fusion Technologies
6.4.1 Market Overview
6.4.2 Market Size and Forecast
6.5 Fracture Treatment
6.5.1 Market Overview
6.5.2 Market Size and Forecast
6.6 Other
6.6.1 Market Overview
6.6.2 Market Size and Forecast
7. Spinal Devices and Biologics Market, By Geography
7.1 Introduction
7.2 North America
7.2.1 North America Spinal Devices and Biologics, By Application
7.2.2 North America Spinal Devices and Biologics, By Type
7.3 Europe
7.3.1 Europe Spinal Devices and Biologics, By Application
7.3.2 Europe Spinal Devices and Biologics, By Type
7.4 Asia-Pacific
7.4.1 Asia-Pacific Spinal Devices and Biologics, By Application
7.4.2 Asia-Pacific Spinal Devices and Biologics, By Type
7.5 Rest of the World
7.5.1 Rest of the World Spinal Devices and Biologics, By Application
7.5.2 Rest of the World Spinal Devices and Biologics, By Type
8. Competitive Insights
8.1 Key Insights
8.2 Company Market Share Analysis
8.3 Strategic Outlook
8.3.1 Mergers & Acquisitions
8.3.2 New Product Development
8.3.3 Portfolio/Production Capacity Expansions
8.3.4 Joint Ventures, Collaborations, Partnerships & Agreements
8.3.5 Others
9. Company Profiles
9.1 Nuvasive
9.1.1 Company Overview
9.1.2 Product/Service Landscape
9.1.3 Financial Overview
9.1.4 Recent Developments
9.2 Orthofix International
9.2.1 Company Overview
9.2.2 Product/Service Landscape
9.2.3 Financial Overview
9.2.4 Recent Developments
9.3 Exactech
9.3.1 Company Overview
9.3.2 Product/Service Landscape
9.3.3 Financial Overview
9.3.4 Recent Developments
9.4 Wright Medical Group
9.4.1 Company Overview
9.4.2 Product/Service Landscape
9.4.3 Financial Overview
9.4.4 Recent Developments
9.5 Johnson & Johnson
9.5.1 Company Overview
9.5.2 Product/Service Landscape
9.5.3 Financial Overview
9.5.4 Recent Developments
9.6 Zimmer Biomet
9.6.1 Company Overview
9.6.2 Product/Service Landscape
9.6.3 Financial Overview
9.6.4 Recent Developments
9.7 Globus Medical
9.7.1 Company Overview
9.7.2 Product/Service Landscape
9.7.3 Financial Overview
9.7.4 Recent Developments
9.8 K2M
9.8.1 Company Overview
9.8.2 Product/Service Landscape
9.8.3 Financial Overview
9.8.4 Recent Developments
9.9 Medtronic
9.9.1 Company Overview
9.9.2 Product/Service Landscape
9.9.3 Financial Overview
9.9.4 Recent Developments
9.10 Alphatec Holdings
9.10.1 Company Overview
9.10.2 Product/Service Landscape
9.10.3 Financial Overview
9.10.4 Recent Developments
The Spinal Devices and Biologics Market has been segmented as below:
Spinal Devices and Biologics Market, By Application
Spinal Devices and Biologics Market, By Type
Spinal Devices and Biologics Market, By Region
Spinal Devices and Biologics Market, By Company
SUBSCRIBE TO OUR NEWSLETTERS
